Form D · Biotechnology
Cardio Diagnostics Holdings, Inc.
Chicago, IL · CIK 0001870144
Offering snapshot reported Feb 6, 2024 · SEC filing
- Reported sold
- $1M Offering amount: $1M
- Investors reported
- 7 Form D · investor count
- Minimum accepted
- $50K Reported outside-investor minimum
- First sale
- Feb 2, 2024 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Feb 6, 2024 | Initial | $1,000,000 | No comparison | 7 | SEC filing |
Offering details
- Securities
- Equity, Option to acquire, Other
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $100K
- Finders' fees
- $0
- Form D file number
- 021-504451
Common Stock and Warrants to Purchase Common Stock
Placement agent fees
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| Altitude Capital Group LLC | 325198 |
Source: Form D, filed Feb 6, 2024. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Paul Burton | Director |
| Meeshanthini Dogan | Director, Executive |
| Warren Hosseinionn | Director |
| James Intrater | Director |
| Stanley Lau | Director |
| Oded Levy | Director |
| Elisa Luqman | Executive |
| Robert Philibert | Director, Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
311 W. Superior Street Suite 444
Chicago, IL, 60645
Chicago, IL, 60645